Logo image of SPAI

SAFE PRO GROUP INC (SPAI) Stock Fundamental Analysis

NASDAQ:SPAI - Nasdaq - US78642D1019 - Common Stock - Currency: USD

4.02  +0.17 (+4.42%)

After market: 4.02 0 (0%)

Fundamental Rating

2

SPAI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. SPAI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SPAI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SPAI had negative earnings in the past year.
SPAI Yearly Net Income VS EBIT VS OCF VS FCFSPAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 -2M -4M -6M

1.2 Ratios

SPAI's Return On Assets of -225.67% is on the low side compared to the rest of the industry. SPAI is outperformed by 96.88% of its industry peers.
The Return On Equity of SPAI (-291.90%) is worse than 81.25% of its industry peers.
Industry RankSector Rank
ROA -225.67%
ROE -291.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPAI Yearly ROA, ROE, ROICSPAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -100 -200 -300

1.3 Margins

SPAI's Gross Margin of 34.43% is fine compared to the rest of the industry. SPAI outperforms 76.56% of its industry peers.
SPAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPAI Yearly Profit, Operating, Gross MarginsSPAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 -200 -400 -600

6

2. Health

2.1 Basic Checks

SPAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SPAI has about the same amount of shares outstanding.
SPAI has a worse debt/assets ratio than last year.
SPAI Yearly Shares OutstandingSPAI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M 10M
SPAI Yearly Total Debt VS Total AssetsSPAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 1M 2M 3M 4M

2.2 Solvency

SPAI has an Altman-Z score of 15.93. This indicates that SPAI is financially healthy and has little risk of bankruptcy at the moment.
SPAI has a Altman-Z score of 15.93. This is amongst the best in the industry. SPAI outperforms 96.88% of its industry peers.
SPAI has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
SPAI has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. SPAI outperforms 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 15.93
ROIC/WACCN/A
WACC9.25%
SPAI Yearly LT Debt VS Equity VS FCFSPAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 1M -1M 2M -2M

2.3 Liquidity

SPAI has a Current Ratio of 3.19. This indicates that SPAI is financially healthy and has no problem in meeting its short term obligations.
SPAI's Current ratio of 3.19 is fine compared to the rest of the industry. SPAI outperforms 75.00% of its industry peers.
SPAI has a Quick Ratio of 2.83. This indicates that SPAI is financially healthy and has no problem in meeting its short term obligations.
SPAI has a Quick ratio of 2.83. This is amongst the best in the industry. SPAI outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.83
SPAI Yearly Current Assets VS Current LiabilitesSPAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M

0

3. Growth

3.1 Past

The earnings per share for SPAI have decreased strongly by -1143.76% in the last year.
The Revenue for SPAI has decreased by -20.24% in the past year. This is quite bad
EPS 1Y (TTM)-1143.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-20.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPAI Yearly Revenue VS EstimatesSPAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 200K 400K 600K 800K 1M
SPAI Yearly EPS VS EstimatesSPAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

SPAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPAI Price Earnings VS Forward Price EarningsSPAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPAI Per share dataSPAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SPAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SAFE PRO GROUP INC

NASDAQ:SPAI (2/21/2025, 8:00:02 PM)

After market: 4.02 0 (0%)

4.02

+0.17 (+4.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.22%
Inst Owner Change43.36%
Ins Owners60.78%
Ins Owner Change-3.41%
Market Cap55.32M
AnalystsN/A
Price TargetN/A
Short Float %7.45%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 25.15
P/FCF N/A
P/OCF N/A
P/B 13.06
P/tB 21.6
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.16
BVpS0.31
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -225.67%
ROE -291.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.43%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.19
Quick Ratio 2.83
Altman-Z 15.93
F-ScoreN/A
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1143.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1154.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-293.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-285.7%
OCF growth 3YN/A
OCF growth 5YN/A